| Association of black race with prostate cancer–specific and other-cause mortality RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ... JAMA oncology 5 (7), 975-983, 2019 | 344 | 2019 |
| Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019 | 292 | 2019 |
| Prostate cancer radiation therapy recommendations in response to COVID-19 NG Zaorsky, BY James, SM McBride, RT Dess, WC Jackson, BA Mahal, ... Advances in radiation oncology 5, 26-32, 2020 | 184 | 2020 |
| A systematic review of the evidence for the decipher genomic classifier in prostate cancer NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ... European urology 79 (3), 374-383, 2021 | 113 | 2021 |
| Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis JL Liss, S Seleri Assunção, J Cummings, A Atri, DS Geldmacher, ... Journal of internal medicine 290 (2), 310-334, 2021 | 111 | 2021 |
| Very early salvage radiotherapy improves distant metastasis-free survival A Abugharib, WC Jackson, V Tumati, RT Dess, JY Lee, SG Zhao, ... The Journal of urology 197 (3 Part 1), 662-668, 2017 | 91 | 2017 |
| Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis LA Gharzai, R Jiang, D Wallington, G Jones, S Birer, N Jairath, ... The Lancet Oncology 22 (3), 402-410, 2021 | 90 | 2021 |
| Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic HE Hartman, Y Sun, TP Devasia, EC Chase, NK Jairath, RT Dess, ... JAMA oncology 6 (12), 1881-1889, 2020 | 88 | 2020 |
| Effect of surface ozone exposures on vegetation grown in the Southern Appalachian Mountains: Identification of possible areas of concern AS Lefohn, W Jackson, DS Shadwick, HP Knudsen Atmospheric Environment 31 (11), 1695-1708, 1997 | 83 | 1997 |
| Job demands and resources among healthcare professionals during virus pandemics: A review and examination of fluctuations in mental health strain during COVID‐19 TW Britt, ML Shuffler, RL Pegram, P Xoxakos, PJ Rosopa, E Hirsh, ... Applied Psychology 70 (1), 120-149, 2021 | 71 | 2021 |
| Independent surgical validation of the new prostate cancer grade‐grouping system DE Spratt, AI Cole, GS Palapattu, AZ Weizer, WC Jackson, ... BJU international 118 (5), 763-769, 2016 | 70 | 2016 |
| Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer RT Dess, Y Sun, WC Jackson, NK Jairath, AU Kishan, DG Wallington, ... JAMA oncology 6 (5), 735-743, 2020 | 68 | 2020 |
| Prostate radiotherapy with adjuvant androgen deprivation therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: an individual patient meta-analysis DE Spratt, S Malone, S Roy, S Grimes, L Eapen, SC Morgan, J Malone, ... Journal of Clinical Oncology 39 (2), 136, 2021 | 67 | 2021 |
| Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases WC Jackson, Y Tao, M Mendiratta-Lala, L Bazzi, DR Wahl, MJ Schipper, ... International Journal of Radiation Oncology* Biology* Physics 100 (4), 950-958, 2018 | 67 | 2018 |
| Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual‐energy x‐ray absorptiometry W Jackson, N Alexander, M Schipper, L Fig, F Feng, S Jolly Head & neck 36 (9), 1356-1362, 2014 | 61 | 2014 |
| Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging … RT Dess, K Suresh, MJ Zelefsky, SJ Freedland, BA Mahal, ... JAMA oncology 6 (12), 1912-1920, 2020 | 59 | 2020 |
| Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition S Han, JC Brenner, A Sabolch, W Jackson, C Speers, K Wilder-Romans, ... Neoplasia 15 (10), 1207-IN36, 2013 | 59 | 2013 |
| Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer DA Hamstra, MH Stenmark, T Ritter, D Litzenberg, W Jackson, S Johnson, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1246-1253, 2013 | 59 | 2013 |
| Organ-sparing in radiotherapy for head-and-neck cancer: Improving quality of life PG Hawkins, AS Kadam, WC Jackson, A Eisbruch Seminars in radiation oncology 28 (1), 46-52, 2018 | 57 | 2018 |
| MDM2 inhibition sensitizes prostate cancer cells to androgen ablation and radiotherapy in a p53-dependent manner FY Feng, Y Zhang, V Kothari, JR Evans, WC Jackson, W Chen, ... Neoplasia 18 (4), 213-222, 2016 | 56 | 2016 |
